Search results for Pharma Stock News

Pharma Stock in Focus After Receiving USFDA Approval for Benzonatate Capsules

Synopsis: The shares of this company rose 8.9 percent following a press release announcing USFDA approval for its Benzonatate Capsules, boosting investor confidence. The share of t...

20% Upper Circuit: Pharma Stock Skyrockets After Announcing Strong Q4 Earnings

Synopsis: The share of this pharma company hit a 20 percent upper circuit after strong Q4 FY26 earnings driven by anesthetic demand, robust margins, and export-led growth momentum....

Healthcare Stock Surges 11% on Strong ANDA Pipeline and 385% Branded Generics Growth in Q4

Synopsis: The share jumps 11 percent on strong Q4 performance, driven by robust ANDA (Abbreviated New Drug Application) pipeline and 385 percent growth in branded generics, signall...

300% Dividend: Pharma Stock Skyrockets 12% After Announcing Q4 Results

Synopsis: RPG Life Sciences reported mixed quarterly numbers, with strong revenue growth but a sharp decline in reported profit due to base effects from last year’s one-time gain....

Pharma Stock Jumps 5% After Announcing Acquisition of Nasdaq-Listed Pharma Firm for ₹1,600 Cr

Synopsis: A leading pharma group expands its US specialty oncology footprint through an all-cash buyout of a Nasdaq-listed firm with an approved cancer supportive-care drug. The In...

Pharma Stock in Focus After Board Approves Buyback of Shares Worth ₹800 Cr

Synopsis: The Hyderabad-based pharma giant has given the green light to repurchase shares at ₹1,475 each, a 10% premium over the current market price.  A major Indian pharma giant...

Pharma Stock Jumps After Receiving Approval for 2 Medicines from Health Canada

Synopsis: Biocon Limited received Health Canada approval for Bosayaâ„¢ and Vevzuoâ„¢, denosumab biosimilars for osteoporosis and cancer-related bone conditions, expanding global re...

Pharma Stock Jumps After Receiving Approval for 2 Cancer-Related Bone Medicines

Synopsis: Biocon Limited received Health Canada approval for Bosayaâ„¢ and Vevzuoâ„¢, denosumab biosimilars for osteoporosis and cancer-related bone conditions, expanding global re...

Hidden Gem: Pharma Stock That Has Entered The US Govt Drug Supply Market

Synopsis: Senores Pharmaceuticals is quietly building a larger global pharma platform with the US at the centre of its growth plan. Backed by a rising ANDA portfolio, acquisitions,...

Specialty Pharma Hits 5% Following International Distribution Order Worth $1.5 Million

Synopsis:- Speciality Medicines Limited, listed on BSE-SME just 23 days ago, has announced a commercial distribution arrangement with an unnamed international entity for pharmaceut...

Pharma Stock Hits 5% Upper Circuit After Board Approves SME-to-Main Board Migration

Synopsis: Pharma stock hit a 5% upper circuit after approving migration from BSE SME to BSE Main Board and filing for NSE Main Board listing, and has initiated a postal ballot to s...

Pharma Stock in Focus After Board Sets Record Date for 1:5 Stock Split and 1:1 Bonus Issue

Synopsis: Anlon Healthcare Limited set Friday, April 24, 2026, as the record date to determine eligible shareholders for its 1:5 stock split and 1:1 bonus issue. This Micro-cap Pha...

Gland Pharma, Sun Pharmaceutical, Laurus Labs shares zoom up to 16% to hit 52-week highs; here's why

Gland Pharma jumped 15.85 per cent to Rs 2,164.40, while Sun Pharma climbed 1 per cent to Rs 1,896.90. Laurus Labs moved up 0.63 per cent to Rs 1,332.

IPCA Labs, Biocon, Laurus Labs, Gland Pharma, Aurobindo, Sun Pharma shares hit 52-week highs; what's next?

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...

Corona Remedies Stock Jumps 11% After Strong Q4 Earnings and Strategic Acquisition

Synopsis: Pharma stock surged 11.29 percent after strong Q4 results and a strategic acquisition, supported by 20.2 percent revenue growth and 43.7 percent PAT growth. The share of...

Pharma Stock to Buy Now for 25% Upside Potential; Recommended by Goldman Sachs

Synopsis: Aurobindo Pharma drew brokerage attention after strong Europe-led growth and steady Q4 FY26 performance, with analysts highlighting margin stability and positive medium-t...

Pharma stock jumps 9% after signing $11.75 Bil deal to acquire US-based firm

Synopsis:- Sun Pharmaceutical Industries has signed a definitive agreement to acquire Organon & Co. for $14 per share in an all-cash deal worth $11.75 billion in enterprise val...

<![CDATA[Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees ]]>

₹94 Pharma-Chemical Stock: Global Ibuprofen Leader With New API Expansion Plans

Synopsis: This Pharma-Chemical stock is a global Ibuprofen leader with a large integrated manufacturing base, low debt and new API expansion plans. But the bigger question is wheth...

2 Stocks Riding the $100 Billion GLP-1 Weight-Loss Wave in India

Synopsis: The global obesity drug boom is minting winners in unexpected places. As pharma giants race to supply GLP-1 therapies, two Indian manufacturers one making the device, ano...

Anupam Rasayan in Focus After Acquiring Up to 48% Stake in Bliss GVS Pharma

Synopsis: Anupam Rasayan India Limited, a leading specialty chemicals company, announced on May 23, 2026, that it has signed a definitive agreement to acquire a 43.3% – 48.2% equit...

Windlas Biotech Jumps 6% as Board Set to Consider Buyback on April 17

Synopsis: With a debt-free balance sheet and steady cash flows, Windlas Biotech Limited has informed exchanges that its board will meet on April 17, 2026, to consider an equity sha...

Can Beta Drugs Boost Exports via Approvals in Azerbaijan and Southeast Asia?

Synopsis:- Shares gained 7% after regulatory progress in Azerbaijan and the Philippines boosted sentiment. Expected GMP approval and CPR clearances improve export visibility. With...

Rs 800 cr share buyback announced by pharma firm: Check record date, purchase price, shareholding pattern

The company has fixed April 17, 2026, as the record date to determine the eligibility of shareholders who can participate in the buyback.